Back to Journals » Lung Cancer: Targets and Therapy » Volume 5

Clinical potential of nintedanib for the second-line treatment of advanced non-small-cell lung cancer: current evidence

Total article views   Abstract views HTML views PDF downloads Totals
4,345 Dovepress* 3,445 791+ 1,361 4,236
PubMed Central* 0 109 26 109
Totals 3,445 900 1,387 4,345
*Since 1 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar